Grail has signed a collaborative agreement with Premier to use that company's PINC AI technology and services platform to expand patient access to Grail's Galleri early cancer detection blood test.
PINC AI will offer clinicians decision support for assessing whether patients at elevated cancer risk could benefit from Galleri through an alert function, Grail said. Community Health Network of Indianapolis is the first health system that will pilot the service.
Galleri can detect more than 50 types of cancer through a blood sample, according to Grail. It is intended to be used in addition to recommended cancer screening exams.
